First Trust Nasdaq Pharmaceuticals ETF (USD) (FTXH, US33738R8372)

Name: FTXH - First Trust Nasdaq Pharmaceuticals ETF (USD), US33738R8372 | Cbonds
Creator: Cbonds
License: https://creativecommons.org/licenses/by/4.0/

(%)

25.97 USD

NAV Per Share

Exchange Traded Funds (ETF)

Type of fund

Equity

Investment category

Healthcare

Sector

USA

Investor locations

20/09/2016

Inception Date

19.48 mln USD

Total assets of the fund

0.6 %

Total Cost Ratio

Nasdaq US Smart Pharmaceuticals Index

Benchmark

First Trust

Provider

19.48 mln USD

Stock class assets

4 times per year

Dividend payments

Replication method

Minimum entry threshold

Split

US33738R8372

ISIN

FTXH

Ticker

CEOXMX

CFI

explore the most comprehensive database

800 000

bonds globally

Over 400

pricing sources

80 000

stocks

9 000

ETF

track your portfolio in the most efficient way

Bond Search

Watchlist

Excel ADD-IN

Get access

— Are you looking for the complete & verified bond data?

— We have everything you need:

full data on over 700 000 bonds, stocks & ETFs; powerful bond screener; over 350 pricing sources among stock exchanges & OTC market; ratings & financial reports; user-friendly interface; available anywhere via Website, Excel Add-in and Mobile app.

Why

You will have detailed descriptive & pricing data for 650K bonds, 76K stocks, 8K ETFs

Get full access to the platform from any device & via Cbonds app

Enhance your portfolio management with Cbonds Excel Add-in

Build yield maps, make chart comparison within a click

Don't wait any longer — start using Cbonds today! Register

Latest data on

Quotes (FTXH)

Yield on 30/04/2024

YTD

-4.36 %
1M

-7.21 %
3M

-4.39 %
6M

9.01 %
1Y

-0.88 %
3Y

4.29 %
5Y

31.25 %
10Y

-

At the price on the exchange, taking into account income payments

Price dynamics

Structure on 29/04/2024

Paper	Value
Merck & Co., Inc.	7.76%
Pfizer Inc.	7.32%
AbbVie Inc.	6.95%
Johnson & Johnson	6.9%
Bristol-Myers Squibb Company	6.67%
Amgen Inc.	3.83%
Biogen Inc.	3.76%
Eli Lilly and Company	3.71%
United Therapeutics Corporation	3.63%
Viatris Inc.	3.61%
Vertex Pharmaceuticals Incorporated	3.57%
Regeneron Pharmaceuticals, Inc.	3.5%
Cardinal Health, Inc.	3.48%
Gilead Sciences, Inc.	3.47%
Jazz Pharmaceuticals Plc	3.11%
Zoetis Inc.	3.05%
Organon & Co.	2.84%
Charles River Laboratories International, Inc.	2.06%
Perrigo Company Plc	1.59%
Medpace Holdings, Inc.	1.52%
Halozyme Therapeutics, Inc.	1.27%
Alkermes Plc	0.99%
Exelixis, Inc.	0.98%
Incyte Corporation	0.96%
Neurocrine Biosciences, Inc.	0.91%
Prestige Consumer Healthcare Inc.	0.86%
Elanco Animal Health Incorporated	0.72%
Illumina, Inc.	0.63%
Intra-Cellular Therapies, Inc.	0.55%
Exact Sciences Corporation	0.54%
Blueprint Medicines Corporation	0.53%
Sarepta Therapeutics, Inc.	0.53%
Krystal Biotech, Inc.	0.52%
Roivant Sciences Ltd.	0.52%
Viking Therapeutics, Inc.	0.52%
BioMarin Pharmaceutical Inc.	0.5%
Arcellx, Inc.	0.49%
Merus NV	0.49%
Ionis Pharmaceuticals, Inc.	0.49%
IDEAYA Biosciences, Inc.	0.48%
Rhythm Pharmaceuticals, Inc.	0.47%
MoonLake Immunotherapeutics (Class A)	0.46%
Ultragenyx Pharmaceutical Inc.	0.45%
Kymera Therapeutics, Inc.	0.43%
Nuvalent, Inc. (Class A)	0.43%
TG Therapeutics, Inc.	0.41%
ACADIA Pharmaceuticals Inc.	0.39%
Arvinas, Inc.	0.37%
CRISPR Therapeutics AG	0.34%
Beam Therapeutics Inc.	0.3%
US Dollar	0.14%

Show more Hide

Download structure in Excel